Keyphrases
Long QT Syndrome
100%
Brugada Syndrome
95%
Arrhythmia
73%
Idiopathic Ventricular Fibrillation
68%
Ventricular Fibrillation
64%
Torsades Des Pointes
63%
Ventricular Arrhythmia
60%
QT Interval
47%
Polymorphic Ventricular Tachycardia
45%
Congenital Long QT Syndrome
44%
Beta-blockers
40%
Implantable Defibrillator
39%
Sudden Death
38%
Myocardial Infarction
38%
Quinidine
38%
Radiofrequency Ablation
37%
Electrophysiological Study
36%
Ventricular Tachycardia
35%
Acute Myocardial Infarction
34%
Electrophysiologic
30%
Adenosine Triphosphate
29%
Atrioventricular Block
26%
Heart Rate
26%
Sinus Rhythm
26%
Catheter
26%
Cardiac Arrest
25%
Antiarrhythmic Drugs
25%
Risk Stratification
24%
Syncope
24%
QT Prolongation
23%
Catecholaminergic Polymorphic Ventricular Tachycardia
23%
Atrial Fibrillation
22%
Flecainide
21%
Amiodarone
21%
Healthy Individuals
21%
AV Nodal Reentrant Tachycardia
21%
Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
20%
Early Repolarization
20%
Accessory Pathway
20%
Defibrillator
20%
Clinical Characteristics
19%
Supraventricular Tachycardia
18%
Consecutive Patients
17%
Arrhythmic Storm
17%
Genotype
17%
Healthy Controls
17%
Exercise-induced
16%
Bedside Test
16%
Left Bundle Branch Block
15%
Non-invasive Diagnosis
15%
Medicine and Dentistry
Brugada Syndrome
77%
Idiopathic Ventricular Fibrillation
65%
Ventricular Fibrillation
63%
Ventricular Tachycardia
56%
Cardiac Dysrhythmia
54%
Long QT Syndrome
47%
Heart Ventricle Arrhythmia
42%
Defibrillator
40%
Repolarization
39%
Implantable Automatic Defibrillator
39%
Radiofrequency Ablation
36%
Electrocardiogram
35%
Polymorphic Ventricular Tachycardia
33%
Sudden Death
30%
Faintness
26%
Heart Arrest
25%
Myocardial Infarction
24%
Adenosine Triphosphate
24%
Atrial Fibrillation
24%
Antiarrhythmic Agent
24%
Risk Stratification
23%
Monomorphic Ventricular Tachycardia
20%
Accessory Pathway
19%
Atrioventricular Nodal Reentry Tachycardia
19%
Amiodarone
18%
Heart Disease
18%
J Wave
18%
Torsade Des Pointes
18%
QT Interval
18%
Sinus Rhythm
17%
Congestive Heart Failure
17%
Supraventricular Tachycardia
17%
Quinidine
17%
Left Bundle Branch Block
15%
Mortality Rate
15%
Cardiac Resynchronization Therapy
14%
Diseases
14%
Athletes
13%
Sudden Cardiac Death
13%
Prevalence
12%
Pulmonary Vein Isolation
12%
Pulmonary Vein
12%
QT Prolongation
11%
Ejection Fraction
11%
Cardiovascular System
11%
T Wave
10%
Catheter Ablation
10%
Palpitations
9%
Cellular Mechanism
9%
Magnesium Sulfate
9%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Ventricle Fibrillation
80%
Long QT Syndrome
66%
Heart Arrhythmia
60%
Heart Ventricle Tachycardia
45%
Torsade Des Pointes
44%
Heart Ventricle Arrhythmia
40%
Brugada Syndrome
39%
Acute Heart Infarction
33%
Quinidine
31%
Heart Infarction
28%
Polymorphic Ventricular Tachycardia
21%
Atrial Fibrillation
20%
Sudden Death
19%
Flecainide
18%
Faintness
17%
Atrioventricular Block
16%
Catecholaminergic Polymorphic Ventricular Tachycardia
16%
Adenosine Triphosphate
14%
Antiarrhythmic Agent
14%
Normal Human
14%
Supraventricular Tachycardia
13%
Heart Arrest
13%
Amiodarone
13%
Beta Adrenergic Receptor Blocking Agent
13%
Heart Disease
12%
Ischemic Heart Disease
11%
Long QT Syndrome 3
10%
Atrioventricular Nodal Reentry Tachycardia
10%
Verapamil
10%
Ischemia
10%
Syndrome
10%
Ranolazine
9%
Tachycardia
9%
Paroxysmal Atrial Fibrillation
9%
QT Prolongation
8%
Infarction
8%
Recurrent Disease
8%
Paroxysmal Supraventricular Tachycardia
7%
Calcium Channel Blocker
7%
Clinical Trial
7%
Adenosine
6%
Population Study
6%
Monomorphic Ventricular Tachycardia
6%
Antiarrhythmic Drug
6%
Mortality Rate
5%
Arrhythmogenesis
5%
Thorax Pain
5%
Sodium Channel
5%
Heart Ventricle Extrasystole
5%
Sudden Cardiac Death
5%